Departments of Psychiatry and Translational Medicine, UMC Brain Center, University Medical Center Utrecht, Utrecht University; and Second Opinion Out-patient Clinic, GGNet Mental Health, Warnsveld, The Netherlands.
Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, The Netherlands; and Department of Medical Humanities, Amsterdam UMC, The Netherlands.
Br J Psychiatry. 2020 Sep;217(3):471-474. doi: 10.1192/bjp.2020.92.
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
在 COVID-19 大流行期间，精神药物治疗有时可能会受到影响。一个潜在的原因是缺乏 COVID-19 特异性精神药理学指南。在这里，我们根据临床经验和药理学背景知识讨论了五个需要考虑的问题，以便在 COVID-19 大流行期间能够安全且有依据地进行精神药理学治疗。
